JP Morgan Chase’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56 Hold
19
﹤0.01% 7349
2025
Q4
$67 Sell
19
-1,000
-98% -$6.76K ﹤0.01% 7245
2025
Q3
$9.35K Hold
1,019
﹤0.01% 6656
2025
Q2
$6.42K Buy
1,019
+996
+4,330% +$7.79K ﹤0.01% 6386
2025
Q1
$187 Hold
23
﹤0.01% 6806
2024
Q4
$258 Sell
23
-22
-49% -$326 ﹤0.01% 6880
2024
Q3
$878 Sell
45
-1,116
-96% -$29.2K ﹤0.01% 6738
2024
Q2
$26.1K Buy
1,161
+156
+16% +$4.66K ﹤0.01% 6073
2024
Q1
$51.7K Buy
1,005
+482
+92% +$26.8K ﹤0.01% 5928
2023
Q4
$36.9K Buy
523
+6
+1% +$414 ﹤0.01% 6095
2023
Q3
$38K Sell
517
-118
-19% -$12.3K ﹤0.01% 5888
2023
Q2
$95K Buy
635
+263
+71% +$36.4K ﹤0.01% 5484
2023
Q1
$20K Buy
372
+97
+35% +$5.83K ﹤0.01% 5974
2022
Q4
$25K Buy
275
+11
+4% +$2.38K ﹤0.01% 5818
2022
Q3
$61K Sell
264
-8
-3% -$2K ﹤0.01% 5477
2022
Q2
$51K Buy
272
+42
+18% +$11.7K ﹤0.01% 5649
2022
Q1
$90K Buy
+230
New +$69K ﹤0.01% 5556
2021
Q4
Sell
-6,000
Closed -$2.96M 6882
2021
Q3
$2.96M Buy
6,000
+3,000
+100% +$1.48M ﹤0.01% 3462
2021
Q2
$1.48M Buy
+3,000
New +$1.47M ﹤0.01% 4019

Other funds holding PIII

JP Morgan Chase's PIII Position: Q1 2026 in Review

JP Morgan Chase held its P3 Health Partners (PIII) position steady in Q1 2026 at 19 shares worth $56. The position accounts for ﹤0.01% of the portfolio, ranked #7349.

JP Morgan Chase first reported a position in PIII in Q2 2021 and has held it in 19 quarters since. The position peaked at $2.96M in Q3 2021. 17 funds tracked by Wall St. Rank hold PIII as of Q1 2026.

  • JP Morgan Chase held 19 shares of P3 Health Partners worth $56 as of Q1 2026.
  • JP Morgan Chase left its P3 Health Partners share count unchanged in Q1 2026.
  • P3 Health Partners made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7349 holding.
  • JP Morgan Chase first reported a position in P3 Health Partners in Q2 2021 and has held it in 19 quarters since.
  • JP Morgan Chase's P3 Health Partners position peaked at $2.96M in Q3 2021.
  • 17 funds tracked by Wall St. Rank held P3 Health Partners as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.